QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 1, 2006, 26(5):1448-1456; doi:10.1523/JNEUROSCI.3777-05.2006

This Article Full Text Full Text (PDF) Supplemental data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Lund, T. D. Articles by Handa, R. J. Search for Related Content PubMed PubMed Citation Articles by Lund, T. D. Articles by Handa, R. J.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
The Androgen 5-Dihydrotestosterone and Its Metabolite 5-Androstan-3, 17-Diol Inhibit the Hypothalamo–Pituitary–Adrenal Response to Stress by Acting through Estrogen Receptor -Expressing Neurons in the Hypothalamus

Trent D. Lund, Laura R. Hinds, and Robert J. Handa

Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523

Correspondence should be addressed to Dr. Trent D. Lund, Department of Biomedical Science, Colorado State University, Anatomy W103, 1617 Campus Delivery, Fort Collins, CO 80523-1670. Email: tlund{at}colostate.edu

Estrogen receptor (ER) and androgen receptor (AR) are found in high levels within populations of neurons in the hypothalamus. To determine whether AR or ER plays a role in regulating hypothalamo–pituitary–adrenal (HPA) axis function by direct action on these neurons, we examined the effects of central implants of 17-estradiol (E2), 5-dihydrotestosterone (DHT), the DHT metabolite 5-androstan-3, 17-diol (3-diol), and several ER subtype-selective agonists on the corticosterone and adrenocorticotropin (ACTH) response to immobilization stress. In addition, activation of neurons in the paraventricular nucleus (PVN) was monitored by examining c-fos mRNA expression. Pellets containing these compounds were stereotaxically implanted near the PVN of gonadectomized male rats. Seven days later, animals were killed directly from their home cage (nonstressed) or were restrained for 30 min (stressed) before they were killed. Compared with controls, E2 and the ER-selective agonists moxestrol and propyl-pyrazole-triol significantly increased the stress induced release of corticosterone and ACTH. In contrast, central administration of DHT, 3-diol, and the ER-selective compound diarylpropionitrile significantly decreased the corticosterone and ACTH response to immobilization. Cotreatment with the ER antagonist tamoxifen completely blocked the effects of 3-diol and partially blocked the effect of DHT, whereas the AR antagonist flutamide had no effect. Moreover, DHT, 3-diol, and diarylpropionitrile treatment significantly decreased restraint-induced c-fos mRNA expression in the PVN. Together, these studies indicate that the inhibitory effects of DHT on HPA axis activity may be in part mediated via its conversion to 3-diol and subsequent binding to ER.

Key words: hypothalamo–pituitary–adrenal axis; estrogen receptor; hypothalamus; dihydrotestosterone; stress; rat

---

Received Dec. 14, 2004; revised Dec. 19, 2004; accepted Dec. 20, 2005.

Correspondence should be addressed to Dr. Trent D. Lund, Department of Biomedical Science, Colorado State University, Anatomy W103, 1617 Campus Delivery, Fort Collins, CO 80523-1670. Email: tlund{at}colostate.edu

This article has been cited by other articles:

				M. Cosma, J. Bailey, J. M. Miles, C. Y. Bowers, and J. D. Veldhuis Pituitary and/or Peripheral Estrogen-Receptor {alpha} Regulates Follicle-Stimulating Hormone Secretion, Whereas Central Estrogenic Pathways Direct Growth Hormone and Prolactin Secretion in Postmenopausal Women J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 951 - 958. [Abstract] [Full Text] [PDF]

				T. R. Pak, W. C. J. Chung, L. R. Hinds, and R. J. Handa Estrogen Receptor-{beta} Mediates Dihydrotestosterone-Induced Stimulation of the Arginine Vasopressin Promoter in Neuronal Cells Endocrinology, July 1, 2007; 148(7): 3371 - 3382. [Abstract] [Full Text] [PDF]

				J. L. Rogers, A. R. Mitchell, C. Maric, K. Sandberg, A. Myers, and S. E. Mulroney Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R794 - R799. [Abstract] [Full Text] [PDF]

				E. R. Rosario, J. C. Carroll, S. Oddo, F. M. LaFerla, and C. J. Pike Androgens Regulate the Development of Neuropathology in a Triple Transgenic Mouse Model of Alzheimer's Disease J. Neurosci., December 20, 2006; 26(51): 13384 - 13389. [Abstract] [Full Text] [PDF]

				K. J. McInnes, A. Corbould, E. R. Simpson, and M. E. Jones Regulation of Adenosine 5',Monophosphate-Activated Protein Kinase and Lipogenesis by Androgens Contributes to Visceral Obesity in an Estrogen-Deficient State Endocrinology, December 1, 2006; 147(12): 5907 - 5913. [Abstract] [Full Text] [PDF]

				S. Gingerich and T. L. Krukoff Estrogen in the Paraventricular Nucleus Attenuates L-Glutamate-Induced Increases in Mean Arterial Pressure Through Estrogen Receptor {beta} and NO Hypertension, December 1, 2006; 48(6): 1130 - 1136. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help